This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Fibrostatin Sociedad Limitada, Fibrostatin, S.l., University of Valencia. Active years: 2013-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2013-2020
Title: Santos Fustero: Innovator in Therapeutic Compounds
Introduction
Santos Fustero is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of therapeutics, particularly in the development of compounds that inhibit GPBP activity. With a total of 3 patents, his work is paving the way for advancements in treating various medical conditions.
Latest Patents
Fustero's latest patents include innovative approaches to GPBP inhibition using Q-peptidomimetics. These compounds are designed to inhibit GPBP activity, making them useful as therapeutics in antibody-mediated disorders, drug-resistant cancer, inflammation, protein misfolding, ER stress-mediated disorders, and aberrant apoptosis. Another patent focuses on GPBP inhibition using Q2 peptidomimetics, which shares similar therapeutic applications.
Career Highlights
Throughout his career, Santos Fustero has worked with prominent organizations such as Fibrostatin, S.L. and Universitat De València. His research and development efforts have significantly impacted the therapeutic landscape, particularly in addressing complex medical challenges.
Collaborations
Fustero has collaborated with esteemed colleagues, including Juan Saus and Juan F. Sanz-Cervera. These partnerships have enhanced his research and contributed to the success of his innovative projects.
Conclusion
Santos Fustero is a distinguished inventor whose work in therapeutic compounds is making a difference in the medical field. His patents and collaborations reflect his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile